Gain Therapeutics, Inc. Profile Avatar - Palmy Investing

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancemen…

Biotechnology
US, Bethesda [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of GANX's Analysis
CIK: 1819411 CUSIP: 36269B105 ISIN: US36269B1052 LEI: - UEI: -
Secondary Listings
GANX has no secondary listings inside our databases.